Intravenous therapy for the treatment of multiple sclerosis | Zendy

Hutchinson Michael | Zendy; Nichol Karl | Zendy; Nellis Mhairi | Zendy; Spicer Jeanette | Zendy; Wolfenden Elspeth | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intravenous therapy for the treatment of multiple sclerosis

Author(s) -

Hutchinson Michael,

Nichol Karl,

Nellis Mhairi,

Spicer Jeanette,

Wolfenden Elspeth

Publication year - 2007

Publication title -

future prescriber

Language(s) - English

Resource type - Journals

eISSN - 1931-2261

pISSN - 1468-9871

DOI - 10.1002/fps.4

Subject(s) - multiple sclerosis , medicine , relapsing remitting , disease , axonal degeneration , central nervous system , physical medicine and rehabilitation , pathology , immunology

Multiple Sclerosis (MS) is a multi‐focal disease of the central nervous system (CNS) that is characterised by inflammation, demyelination and axonal degeneration. In the majority of MS patients, the disease presents with a relapsing remitting course at disease onset. Relapsing remitting MS (RRMS); affects around two thirds of the 85 000 people in the UK with MS. 1 The aims of treatment in RRMS are not only to prevent the rate of relapse, but also to slow down patients' disability progression. Copyright © 2007 Wiley Interface Ltd

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research